2010
DOI: 10.1371/journal.pone.0014066
|View full text |Cite|
|
Sign up to set email alerts
|

A Longitudinal Study of BCG Vaccination in Early Childhood: The Development of Innate and Adaptive Immune Responses

Abstract: BCG vaccine drives a strong T helper 1 cellular immunity which is essential for the protection against mycobacteria, however recent studies suggest that BCG vaccination can have non-specific beneficial effects unrelated to tuberculosis. In the present cohort study the development of cytokine profiles following BCG vaccination was investigated. Immune responses to PPD were assessed before vaccination and at ages of 5 months, 1 year, and 2 years, followed by BCG scar measurement at 4 years of age. BCG was shown … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
36
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(40 citation statements)
references
References 28 publications
2
36
2
Order By: Relevance
“…Furthermore, given that the subjects in our study from South Africa and Ecuador received Bacillus Calmette-Guérin around birth while subjects from Belgium and Canada did not, newborn Bacillus Calmette-Guérin immunization also appears unlikely to be the main driver for observed differences at age 2 years. Of note, Djuardi et al 36 also found no clear effect of Bacillus Calmette-Guérin vaccination on the innate immune ontogeny. While the overall vaccination schedule was similar for all infants across the 4 sites, differences in vaccine composition (eg, acellular vs whole-cell pertussis) or exact age of receipt of vaccines differed; we thus cannot exclude that such variation in standard childhood vaccination might be responsible for our observed differences.…”
Section: Discussionmentioning
confidence: 97%
“…Furthermore, given that the subjects in our study from South Africa and Ecuador received Bacillus Calmette-Guérin around birth while subjects from Belgium and Canada did not, newborn Bacillus Calmette-Guérin immunization also appears unlikely to be the main driver for observed differences at age 2 years. Of note, Djuardi et al 36 also found no clear effect of Bacillus Calmette-Guérin vaccination on the innate immune ontogeny. While the overall vaccination schedule was similar for all infants across the 4 sites, differences in vaccine composition (eg, acellular vs whole-cell pertussis) or exact age of receipt of vaccines differed; we thus cannot exclude that such variation in standard childhood vaccination might be responsible for our observed differences.…”
Section: Discussionmentioning
confidence: 97%
“…A common confounder, which affects TST reactivity, is prior vaccination with BCG vaccine, and/or the strain and dose of BCG used, and/or method of vaccine administration and age at vaccination. Successful vaccination can be assessed by the presence or absence of a BCG scar [11]. Similar finding was emphasized on skin testing in BCG-vaccinated populations to predict LTBI suspicious carriers [12].…”
Section: Discussionmentioning
confidence: 87%
“…Recently, a strong association has been found between IL-5 or IL-13 responses to PPD soon after BCG vaccination and scar formation at 4 years. The authors commented that assessing scar size reflects an early Th2 response induced by BCG rather than generally accepted Th1 responses (29).…”
Section: Discussionmentioning
confidence: 99%